While anti-CENP-A autoantibody (associated with scleroderma), and anti-Ro-60 (associated with SjD) were not informative in the IIM cohort, anti-Ro-52 autoantibody was present in 52% (n=11) of IIM-ILD patients. Here, RO60 is linked to scleroderma.